The historical rank and industry rank for RemeGen Co's Days Inventory or its related term are showing as below:
HKSE:09995'
s Days Inventory Range Over the Past 10 Years
Min: 561.17 Med: 927.61 Max: 1635.72
Current: 1635.72
During the past 6 years, RemeGen Co's highest Days Inventory was 1635.72. The lowest was 561.17. And the median was 927.61.
HKSE:09995's Days Inventory is ranked worse than 94.46% of 650
companies
in the Biotechnology industry
Industry Median: 190.305
vs HKSE:09995: 1635.72
RemeGen Co's Days Inventory
declined
from Sep. 2022 (618.32) to Dec. 2023 (0.00).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
RemeGen Co's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RemeGen Co Days Inventory Historical Data
The historical data trend for RemeGen Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of RemeGen Co's Days Inventory
For the Biotechnology subindustry, RemeGen Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RemeGen Co's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, RemeGen Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where RemeGen Co's Days Inventory falls into.
RemeGen Co Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
RemeGen Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RemeGen Co (HKSE:09995) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
RemeGen Co's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RemeGen Co's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
RemeGen Co Days Inventory Related Terms
Thank you for viewing the detailed overview of RemeGen Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
RemeGen was established in 2008 and listed on the Hong Kong Stock Exchange in 2020. It is a commercial stage biotech company focused on developing drugs to treat autoimmune disease, cancer, and ophthalmic disease for the China market and potentially the global market, as well. Its core assets are disitamab vedotin (RC48), a HER2-targeting antibody-drug conjugate (ADC) for treating HER2-expressing cancers, and telitacicept (RC18), a BLyS and APRIL targeting bispecific fusion protein for treating various B-cell mediated autoimmune diseases. These drugs received their first approvals in China in 2021 and are both covered on the National Reimbursement Drug List (NRDL).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09995 has been successfully added to your 